{"id":28429,"date":"2020-07-14T05:52:50","date_gmt":"2020-07-14T05:52:50","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=28429"},"modified":"2020-07-14T05:52:50","modified_gmt":"2020-07-14T05:52:50","slug":"norepinephrine-dopamine-reuptake-inhibitors-ndris","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/","title":{"rendered":"Norepinephrine-dopamine reuptake inhibitors (NDRIs)"},"content":{"rendered":"<p>A class of medications that increase the levels of both norepinephrine and dopamine, inhibiting their reabsorption back into presynaptic neurons. Examples of NDRIs include the mild central nervous system (CNS) stimulants dexmethylphenidate and methylphenidate.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A class of medications that increase the levels of both norepinephrine and dopamine, inhibiting their reabsorption back into presynaptic neurons. Examples of NDRIs include the mild central nervous system (CNS) stimulants dexmethylphenidate and methylphenidate. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-28429","post","type-post","status-publish","format-standard","hentry","category-n"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Norepinephrine-dopamine reuptake inhibitors (NDRIs) - Definition of Norepinephrine-dopamine reuptake inhibitors (NDRIs)<\/title>\n<meta name=\"description\" content=\"A class of medications that increase the levels of both norepinephrine and dopamine, inhibiting their reabsorption back into presynaptic neurons. Examples of NDRIs include the mild central nervous system (CNS) stimulants dexmethylphenidate and methylphenidate.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Norepinephrine-dopamine reuptake inhibitors (NDRIs) - Definition of Norepinephrine-dopamine reuptake inhibitors (NDRIs)\" \/>\n<meta property=\"og:description\" content=\"A class of medications that increase the levels of both norepinephrine and dopamine, inhibiting their reabsorption back into presynaptic neurons. Examples of NDRIs include the mild central nervous system (CNS) stimulants dexmethylphenidate and methylphenidate.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-14T05:52:50+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/\",\"name\":\"Norepinephrine-dopamine reuptake inhibitors (NDRIs) - Definition of Norepinephrine-dopamine reuptake inhibitors (NDRIs)\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-14T05:52:50+00:00\",\"dateModified\":\"2020-07-14T05:52:50+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A class of medications that increase the levels of both norepinephrine and dopamine, inhibiting their reabsorption back into presynaptic neurons. Examples of NDRIs include the mild central nervous system (CNS) stimulants dexmethylphenidate and methylphenidate.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Norepinephrine-dopamine reuptake inhibitors (NDRIs)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Norepinephrine-dopamine reuptake inhibitors (NDRIs) - Definition of Norepinephrine-dopamine reuptake inhibitors (NDRIs)","description":"A class of medications that increase the levels of both norepinephrine and dopamine, inhibiting their reabsorption back into presynaptic neurons. Examples of NDRIs include the mild central nervous system (CNS) stimulants dexmethylphenidate and methylphenidate.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/","og_locale":"en_US","og_type":"article","og_title":"Norepinephrine-dopamine reuptake inhibitors (NDRIs) - Definition of Norepinephrine-dopamine reuptake inhibitors (NDRIs)","og_description":"A class of medications that increase the levels of both norepinephrine and dopamine, inhibiting their reabsorption back into presynaptic neurons. Examples of NDRIs include the mild central nervous system (CNS) stimulants dexmethylphenidate and methylphenidate.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/","og_site_name":"Glossary","article_published_time":"2020-07-14T05:52:50+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/","name":"Norepinephrine-dopamine reuptake inhibitors (NDRIs) - Definition of Norepinephrine-dopamine reuptake inhibitors (NDRIs)","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-14T05:52:50+00:00","dateModified":"2020-07-14T05:52:50+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A class of medications that increase the levels of both norepinephrine and dopamine, inhibiting their reabsorption back into presynaptic neurons. Examples of NDRIs include the mild central nervous system (CNS) stimulants dexmethylphenidate and methylphenidate.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/norepinephrine-dopamine-reuptake-inhibitors-ndris\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Norepinephrine-dopamine reuptake inhibitors (NDRIs)"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28429","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=28429"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28429\/revisions"}],"predecessor-version":[{"id":28430,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/28429\/revisions\/28430"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=28429"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=28429"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=28429"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}